Palmetto: Serenoa repens (W. Bartram) Small

image

Saw Palmetto


Serenoa repens (W. Bartram) Small


Synonym:


Sabal serrulata (Michx.) Schult.f.


Family:


Arecaceae (Palmae)


Other common names:


American dwarf palm; sabal


Drug name:


Sabalis serrulatae fructus


Botanical drug used:


Dried ripe fruit


Main chemical compounds:


Free fatty acids such as capric, caproic, caprylic, lauric, myristic, oleic, linoleic, linolenic, stearic and palmitic acids, and phytosterols such as β-sitosterol, stigmasterol, campesterol and β-sitosterol 3-O-D-glucoside. Flavonoids including rutin, kaempferol and isoquercetin, and carotenoids are also present (Booker et al. 2014; ESCOP 2003; Williamson et al. 2013).


Clinical evidence:


Benign prostrate hyperplasia:


More than 90 clinical trials on the use of saw palmetto in BPH have been published but the overall evidence is conflicting. The most recent Cochrane Review concluded that ‘at double and triple doses, [saw palmetto] did not improve urinary flow measures or prostate size in men with lower urinary tract symptoms consistent with BPH’ (Tacklind et al. 2012). Earlier reviews by the Cochrane Collaboration (2000 and 2002) provided a more positive overall assessment but the shift was mainly due to a large placebo controlled clinical trial, carried out in the United States, which had a negative outcome (Barry et al. 2011). In the same study, saw palmetto extract did not affect serum prostate specific antigen more than placebo, even at relatively high doses (Andriole et al. 2013).


Sexual dysfunction associated with BPH:

Stay updated, free articles. Join our Telegram channel

Nov 25, 2016 | Posted by in PHARMACY | Comments Off on Palmetto: Serenoa repens (W. Bartram) Small

Full access? Get Clinical Tree

Get Clinical Tree app for offline access